Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Finasteride Treatment of Severe Nodulocystic Acne [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating finasteride for severe nodulocystic acne has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: Elorac, Inc. | Conditions: NODULOCYSTIC ACNE | Phase 2 | Status: COMPLETED